企業プロフィール
Cyclacel 株価・ニュース・カタリスト
- ティッカー:
- CYCC
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United Kingdom and traded in the U
株価変動の要因
Current closing-price context is not available for CYCC.
企業概要
事業概要
Cyclacel Pharmaceuticals was an oncology-focused company working on cell-cycle and cancer biology before becoming a legacy ticker. Its story centered on using small-molecule mechanisms to attack difficult tumors.
所在地とセクター分類
Cyclacel was headquartered in the United Kingdom and traded in the U.S. market. It sat in small-cap oncology biotechnology.
ビジネスモデルの特徴
The company depended on clinical progress, capital management, and the ability to keep a narrow pipeline advancing. Investors historically tracked readouts and financing needs.
バイオ業界での位置付け
Cyclacel belongs to the historical small-cap oncology biotech bucket. Like many cancer-drug developers, its story was defined by a narrow pipeline and high execution risk.
今後のカタリスト
- Cyclacel is a legacy / closeout story now, so the catalysts are any remaining strategic or asset-resolution update rather than a fresh oncology milestone. Investors are watching residual value.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。